by Clinical Neuropsychologist Online | Tuesday, September 8, 2026 | Neuroscience
Nature Neuroscience, Published online: 08 September 2026; doi:10.1038/s41593-026-02417-7Alzheimer’s disease progression involves reduced bone marrow production of myeloid cells due to type I interferon signaling, which hampers the homing of protective immune cells to...
by Clinical Neuropsychologist Online | Tuesday, September 8, 2026 | Neuroscience
Nature Neuroscience, Published online: 08 September 2026; doi:10.1038/s41593-026-02428-4Intestinal CD4+ T cells migrate to the dura and brain following gut infection with bacteria or parasites, establishing a long-lived memory population capable of proliferation and...
by Clinical Neuropsychologist Online | Tuesday, September 8, 2026 | Neuroscience
Nature Neuroscience, Published online: 08 September 2026; doi:10.1038/s41593-026-02418-6Although Alzheimer’s disease (AD) is a disease of the brain, we demonstrate that it disrupts myeloid cell production in the bone marrow via a type I interferon signal, preventing...
by Clinical Neuropsychologist Online | Monday, September 7, 2026 | Dementia
Abstract BACKGROUND Prevalence of dementia is higher in low- and middle-income countries (LMICs). However, longitudinal studies characterizing cognitive decline and its clinical and epidemiological predictors remain scarce in Brazil. METHODS Participants were enrolled...
by Clinical Neuropsychologist Online | Monday, September 7, 2026 | Dementia
Abstract INTRODUCTION While both Alzheimer’s disease (AD) and cerebral small vessel disease (CSVD) involve vascular dysfunction, the ocular microvascular differences between them remain largely underinvestigated. METHODS This cross-sectional study included 650...
